Clinical Trial Update: Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating KRX-0502 (ferric citrate) for iron deficiency anemia in children with non-dialysis dependent chronic kidney disease has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• KRX-0502 (Ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease | Phase 3 | Status: WITHDRAWN